Department of General Practice, Turku University and Turku University Hospital, 20014 Turku, Finland.
Folkhälsan Research Center, 00250 Helsinki, Finland; Unit of Primary Health Care, Kuopio University Hospital, 70210 Kuopio, Finland.
Eur J Intern Med. 2023 Aug;114:101-107. doi: 10.1016/j.ejim.2023.04.032. Epub 2023 May 6.
Higher than normal estimated glomerular filtration rate (eGFR), i.e. renal hyperfiltration (RHF), has been associated with mortality.
A population-based screening program in Finland identified 1747 apparently healthy middle-aged cardiovascular risk subjects in 2005-2007. GFR was estimated with the creatinine-based Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation indexed for 1.73 m and for the actual body surface area (BSA) of the subjects. This individually corrected eGFR was calculated as eGFR (ml/min/BSA m) = eGFR (ml/min/1.73 m) x (BSA/1.73). BSA was calculated by the Mosteller formula. RHF was defined as eGFR of more than 1.96 SD above the mean eGFR of healthy individuals. All-cause mortality was obtained from the national registry.
The higher the eGFR, the greater was the discrepancy between the two GFR estimating equations. During the 14 years of follow-up, 230 subjects died. There were no differences in mortality rates between the categories of individually corrected eGFR (p = 0.86) when adjusted for age, sex, body mass index, systolic BP, total cholesterol, new diabetes, current smoking, and alcohol use. The highest eGFR category was associated with increased standardized mortality rate (SMR) when CKD-EPI formula indexed for 1.73 m was used, but SMR was at the population level when individually corrected eGFR was applied.
Higher than normal eGFR calculated by the creatinine-based CKD-EPI equation is associated with all-cause mortality when indexed to 1.73 m, but not when indexed to actual BSA of a person. This challenges the current perception of the harmfulness of RHF in apparently healthy individuals.
高于正常的估算肾小球滤过率(eGFR),即肾高滤过(RHF),与死亡率有关。
芬兰的一项基于人群的筛查计划在 2005-2007 年期间确定了 1747 名看似健康的中年心血管风险受试者。使用基于肌酐的慢性肾脏病流行病学合作(CKD-EPI)方程估算 GFR,并对 1.73 m 和受试者的实际体表面积(BSA)进行指数化。通过将 eGFR(ml/min/1.73 m)乘以 BSA/1.73 来计算个体校正后的 eGFR。BSA 通过 Mosteller 公式计算。将 eGFR 超过健康个体平均 eGFR 的 1.96 个标准差定义为 RHF。通过国家登记处获得全因死亡率。
eGFR 越高,两种 GFR 估算方程之间的差异越大。在 14 年的随访期间,有 230 名受试者死亡。当调整年龄、性别、体重指数、收缩压、总胆固醇、新发糖尿病、当前吸烟和饮酒情况时,个体校正后的 eGFR 各分类的死亡率没有差异(p=0.86)。当使用 CKD-EPI 公式对 1.73 m 进行索引时,eGFR 最高分类与标准化死亡率(SMR)升高相关,但当应用个体校正后的 eGFR 时,SMR 处于人群水平。
当使用基于肌酐的 CKD-EPI 方程计算时,高于正常的 eGFR 与全因死亡率相关,当对 1.73 m 进行索引时,但当对个人的实际 BSA 进行索引时则不相关。这挑战了目前对健康个体中 RHF 的危害性的认识。